Detalhe da pesquisa
1.
The influence of plasma sPD-L1 concentration on the effectiveness of immunotherapy in advanced NSCLC patients.
Cancer Immunol Immunother
; 72(12): 4169-4177, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816808
2.
MicroRNA-126 selected with broad-spectrum analysis of microRNAs - a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?
Front Immunol
; 15: 1344858, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469304
3.
Interactions between Dietary Micronutrients, Composition of the Microbiome and Efficacy of Immunotherapy in Cancer Patients.
Cancers (Basel)
; 14(22)2022 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428677
4.
Presence of Akkermansiaceae in gut microbiome and immunotherapy effectiveness in patients with advanced non-small cell lung cancer.
AMB Express
; 12(1): 86, 2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35792976
5.
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.
Cancers (Basel)
; 14(24)2022 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36551735
6.
Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 13(6)2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33799560
7.
Observational cross-sectional study of 5279 bronchoscopy results for the practical effectiveness of various biopsy techniques in the diagnosis of lung diseases with particular emphasis on lung cancer.
BMJ Open
; 11(8): e043820, 2021 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34373288
8.
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.
Front Oncol
; 10: 563613, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33628725